Is a 75 mg tablet of zinc gluconate safe for a 69‑kg pregnant woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is 75 mg Zinc Gluconate Safe for a 69 kg Pregnant Woman?

A 75 mg dose of zinc gluconate is safe for a 69 kg pregnant woman, as this dose falls well below the established safety threshold and aligns with evidence-based recommendations for zinc supplementation during pregnancy.

Safety Assessment Based on Guidelines and Evidence

The 2022 ESPEN micronutrient guideline 1 establishes that zinc toxicity symptoms only appear when ingestion exceeds 1,000-2,000 mg of zinc 1. Your proposed dose of 75 mg is approximately 13-27 times lower than the toxic threshold, providing a substantial safety margin.

Dose Appropriateness for Pregnancy

For acquired zinc deficiency, the ESPEN guideline recommends 0.5-1 mg/kg per day of elemental zinc for 3-4 months, with zinc gluconate specifically noted as having "comparatively better tolerability" than inorganic zinc salts 1.

For a 69 kg woman:

  • Recommended range: 34.5-69 mg elemental zinc per day
  • Your proposed dose: 75 mg zinc gluconate (contains approximately 10-11 mg elemental zinc)
  • This dose is well within safe parameters

Pregnancy-Specific Evidence

The FDA drug label advises pregnant women to "ask a health professional before use" 2, which you are appropriately doing, but does not contraindicate zinc use.

Multiple studies demonstrate safety in pregnancy 3:

  • Over 2,500 pregnant women studied at various zinc doses
  • No abnormalities, congenital malformations, or fetal harm reported at doses below 75 mg/day 3
  • French pharmacovigilance data from approximately 10,000 pregnant women treated annually with zinc gluconate showed only 4 serious adverse events with doubtful causal relationship 3

Research trials using 25-50 mg elemental zinc daily showed beneficial effects on birth weight and head circumference without adverse outcomes 4, 5, 6.

Important Caveats

Pregnancy increases zinc requirements due to embryogenesis and fetal development 1, 3. However:

  • The 2021 Cochrane review found that routine zinc supplementation in non-deficient pregnant women shows little benefit for preventing preterm birth or improving birth outcomes 7
  • Consider checking plasma zinc levels (with simultaneous CRP and albumin) to confirm actual deficiency before long-term supplementation 1

Monitor for non-serious adverse events: While serious adverse events are rare, zinc supplementation may increase risk of minor side effects like nausea or gastrointestinal upset (RR 1.34) 8. Zinc gluconate has better tolerability than zinc sulfate or chloride 1.

Clinical Recommendation

Proceed with the 75 mg zinc gluconate dose, as it is safe and appropriate for pregnancy. This dose provides therapeutic benefit if deficiency exists while remaining far below toxic levels. The organic gluconate form minimizes gastrointestinal side effects 1.

References

Guideline

espen micronutrient guideline.

Clinical Nutrition, 2022

Research

[Acne, pregnant women and zinc salts: a literature review].

Annales de dermatologie et de venereologie, 2008

Research

Effects of zinc supplementation during pregnancy on pregnancy outcome in women with history of preterm delivery: a double-blind randomized, placebo-controlled trial.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2010

Research

The effects of zinc supplementation on clinical response and metabolic profiles in pregnant women at risk for intrauterine growth restriction: a randomized, double-blind, placebo-controlled trial.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2021

Research

Zinc supplementation for improving pregnancy and infant outcome.

The Cochrane database of systematic reviews, 2021

Research

Zinc for prevention and treatment of the common cold.

The Cochrane database of systematic reviews, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.